![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: ADM |
Gene summary for ADM |
![]() |
Gene information | Species | Human | Gene symbol | ADM | Gene ID | 133 |
Gene name | adrenomedullin | |
Gene Alias | AM | |
Cytomap | 11p15.4 | |
Gene Type | protein-coding | GO ID | GO:0000003 | UniProtAcc | P35318 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
133 | ADM | GSM4909282 | Human | Breast | IDC | 5.22e-03 | -2.85e-01 | -0.0288 |
133 | ADM | GSM4909285 | Human | Breast | IDC | 1.23e-09 | -3.62e-01 | 0.21 |
133 | ADM | GSM4909286 | Human | Breast | IDC | 4.79e-07 | -3.65e-01 | 0.1081 |
133 | ADM | GSM4909290 | Human | Breast | IDC | 1.20e-07 | -3.78e-01 | 0.2096 |
133 | ADM | GSM4909293 | Human | Breast | IDC | 1.09e-07 | -3.75e-01 | 0.1581 |
133 | ADM | GSM4909294 | Human | Breast | IDC | 7.44e-06 | -3.73e-01 | 0.2022 |
133 | ADM | GSM4909297 | Human | Breast | IDC | 5.62e-05 | -2.27e-01 | 0.1517 |
133 | ADM | GSM4909298 | Human | Breast | IDC | 3.90e-10 | -3.82e-01 | 0.1551 |
133 | ADM | GSM4909301 | Human | Breast | IDC | 1.30e-08 | -3.60e-01 | 0.1577 |
133 | ADM | GSM4909305 | Human | Breast | IDC | 6.31e-03 | -3.16e-01 | 0.0436 |
133 | ADM | GSM4909306 | Human | Breast | IDC | 1.86e-04 | -3.25e-01 | 0.1564 |
133 | ADM | GSM4909307 | Human | Breast | IDC | 1.51e-07 | -3.46e-01 | 0.1569 |
133 | ADM | GSM4909308 | Human | Breast | IDC | 2.69e-10 | -3.82e-01 | 0.158 |
133 | ADM | GSM4909311 | Human | Breast | IDC | 7.77e-09 | -3.51e-01 | 0.1534 |
133 | ADM | GSM4909312 | Human | Breast | IDC | 3.01e-07 | -3.36e-01 | 0.1552 |
133 | ADM | GSM4909313 | Human | Breast | IDC | 6.70e-03 | -2.86e-01 | 0.0391 |
133 | ADM | GSM4909319 | Human | Breast | IDC | 1.49e-12 | -3.90e-01 | 0.1563 |
133 | ADM | GSM4909320 | Human | Breast | IDC | 3.47e-02 | -3.63e-01 | 0.1575 |
133 | ADM | GSM4909321 | Human | Breast | IDC | 2.34e-05 | -3.11e-01 | 0.1559 |
133 | ADM | ctrl6 | Human | Breast | Precancer | 1.30e-23 | 1.15e+00 | -0.0061 |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:00061121 | Liver | Cirrhotic | energy reserve metabolic process | 31/4634 | 84/18723 | 8.75e-03 | 4.04e-02 | 31 |
GO:00315792 | Liver | Cirrhotic | membrane raft organization | 12/4634 | 25/18723 | 9.84e-03 | 4.42e-02 | 12 |
GO:006102812 | Liver | Cirrhotic | establishment of endothelial barrier | 19/4634 | 46/18723 | 9.90e-03 | 4.44e-02 | 19 |
GO:012025411 | Liver | Cirrhotic | olefinic compound metabolic process | 51/4634 | 153/18723 | 1.03e-02 | 4.61e-02 | 51 |
GO:0044706 | Liver | Cirrhotic | multi-multicellular organism process | 70/4634 | 220/18723 | 1.03e-02 | 4.61e-02 | 70 |
GO:00071624 | Liver | Cirrhotic | negative regulation of cell adhesion | 93/4634 | 303/18723 | 1.06e-02 | 4.66e-02 | 93 |
GO:000609122 | Liver | HCC | generation of precursor metabolites and energy | 340/7958 | 490/18723 | 4.04e-34 | 2.85e-31 | 340 |
GO:001598022 | Liver | HCC | energy derivation by oxidation of organic compounds | 221/7958 | 318/18723 | 1.02e-22 | 1.86e-20 | 221 |
GO:004325422 | Liver | HCC | regulation of protein-containing complex assembly | 264/7958 | 428/18723 | 5.47e-16 | 4.39e-14 | 264 |
GO:000188922 | Liver | HCC | liver development | 108/7958 | 147/18723 | 2.16e-14 | 1.41e-12 | 108 |
GO:006100822 | Liver | HCC | hepaticobiliary system development | 109/7958 | 150/18723 | 5.72e-14 | 3.42e-12 | 109 |
GO:003286821 | Liver | HCC | response to insulin | 172/7958 | 264/18723 | 7.14e-14 | 4.23e-12 | 172 |
GO:000663122 | Liver | HCC | fatty acid metabolic process | 238/7958 | 390/18723 | 8.24e-14 | 4.84e-12 | 238 |
GO:000599621 | Liver | HCC | monosaccharide metabolic process | 167/7958 | 257/18723 | 2.31e-13 | 1.25e-11 | 167 |
GO:001931821 | Liver | HCC | hexose metabolic process | 155/7958 | 237/18723 | 7.63e-13 | 3.90e-11 | 155 |
GO:004343422 | Liver | HCC | response to peptide hormone | 247/7958 | 414/18723 | 9.55e-13 | 4.77e-11 | 247 |
GO:003166722 | Liver | HCC | response to nutrient levels | 276/7958 | 474/18723 | 2.30e-12 | 1.08e-10 | 276 |
GO:001056322 | Liver | HCC | negative regulation of phosphorus metabolic process | 259/7958 | 442/18723 | 4.29e-12 | 1.92e-10 | 259 |
GO:004593622 | Liver | HCC | negative regulation of phosphate metabolic process | 258/7958 | 441/18723 | 6.00e-12 | 2.60e-10 | 258 |
GO:004428221 | Liver | HCC | small molecule catabolic process | 225/7958 | 376/18723 | 6.50e-12 | 2.80e-10 | 225 |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
ADM | CALCRL | ADM_CALCRL | CALCR | Breast | ADJ |
ADM | CALCRL | ADM_CALCRL | CALCR | Breast | DCIS |
CADM1 | CADM1 | CADM1_CADM1 | CADM | Breast | DCIS |
ADM | CALCRL | ADM_CALCRL | CALCR | Breast | Healthy |
ADM | CALCRL | ADM_CALCRL | CALCR | Breast | IDC |
CADM1 | CADM1 | CADM1_CADM1 | CADM | Breast | IDC |
ADM | CALCRL | ADM_CALCRL | CALCR | Breast | Precancer |
ADM | CALCRL | ADM_CALCRL | CALCR | Cervix | ADJ |
ADM | CALCRL | ADM_CALCRL | CALCR | Cervix | CC |
ADM | CALCRL | ADM_CALCRL | CALCR | Cervix | Precancer |
CADM1 | CADM1 | CADM1_CADM1 | CADM | Cervix | Precancer |
CADM1 | CADM1 | CADM1_CADM1 | CADM | CRC | ADJ |
CADM1 | CADM1 | CADM1_CADM1 | CADM | CRC | CRC |
CADM1 | CADM1 | CADM1_CADM1 | CADM | CRC | FAP |
CADM1 | CADM1 | CADM1_CADM1 | CADM | Endometrium | ADJ |
ADM | CALCRL | ADM_CALCRL | CALCR | Endometrium | AEH |
CADM1 | CADM1 | CADM1_CADM1 | CADM | Endometrium | AEH |
ADM | CALCRL | ADM_CALCRL | CALCR | Endometrium | EEC |
CADM1 | CADM1 | CADM1_CADM1 | CADM | Endometrium | EEC |
ADM | CALCRL | ADM_CALCRL | CALCR | Endometrium | Healthy |
Page: 1 2 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
ADM | SNV | Missense_Mutation | rs770053274 | c.224N>A | p.Gly75Asp | p.G75D | P35318 | protein_coding | tolerated(0.97) | benign(0.012) | TCGA-2W-A8YY-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Chemotherapy | cisplatin | CR |
ADM | SNV | Missense_Mutation | novel | c.215N>G | p.Asp72Gly | p.D72G | P35318 | protein_coding | deleterious(0.04) | possibly_damaging(0.478) | TCGA-VS-A953-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Unknown | Unknown | PD |
ADM | SNV | Missense_Mutation | c.448C>T | p.Arg150Cys | p.R150C | P35318 | protein_coding | deleterious(0) | probably_damaging(1) | TCGA-A6-5661-01 | Colorectum | colon adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |
ADM | SNV | Missense_Mutation | c.20N>T | p.Ala7Val | p.A7V | P35318 | protein_coding | deleterious(0.02) | benign(0.078) | TCGA-AA-3510-01 | Colorectum | colon adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | SD | |
ADM | insertion | Frame_Shift_Ins | rs773405081 | c.523_524insC | p.Ser178GlufsTer19 | p.S178Efs*19 | P35318 | protein_coding | TCGA-G4-6588-01 | Colorectum | colon adenocarcinoma | Female | <65 | I/II | Unknown | Unknown | SD | ||
ADM | insertion | Frame_Shift_Ins | rs773405081 | c.523_524insC | p.Ser178GlufsTer19 | p.S178Efs*19 | P35318 | protein_coding | TCGA-WS-AB45-01 | Colorectum | colon adenocarcinoma | Female | <65 | I/II | Unknown | Unknown | SD | ||
ADM | SNV | Missense_Mutation | c.155N>G | p.Tyr52Cys | p.Y52C | P35318 | protein_coding | tolerated(0.16) | possibly_damaging(0.819) | TCGA-D1-A15X-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD | |
ADM | SNV | Missense_Mutation | novel | c.553N>A | p.Leu185Ile | p.L185I | P35318 | protein_coding | deleterious_low_confidence(0) | benign(0.011) | TCGA-E6-A1LX-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
ADM | insertion | Frame_Shift_Ins | rs773405081 | c.523_524insC | p.Ser178GlufsTer19 | p.S178Efs*19 | P35318 | protein_coding | TCGA-AP-A1DO-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD | ||
ADM | insertion | Frame_Shift_Ins | rs773405081 | c.530dupC | p.Ser178GlufsTer19 | p.S178Efs*19 | P35318 | protein_coding | TCGA-EO-A22U-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
Page: 1 2 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
133 | ADM | DRUGGABLE GENOME, HORMONE ACTIVITY | PD-98059 | CHEMBL35482 | 10830296 | |
133 | ADM | DRUGGABLE GENOME, HORMONE ACTIVITY | NSC-87877 | CHEMBL472004 | 22884224 | |
133 | ADM | DRUGGABLE GENOME, HORMONE ACTIVITY | INDOMETHACIN | INDOMETHACIN | 10830296 | |
133 | ADM | DRUGGABLE GENOME, HORMONE ACTIVITY | NSC-106221 | CHEMBL2063510 | 22884224 | |
133 | ADM | DRUGGABLE GENOME, HORMONE ACTIVITY | paroxetine | PAROXETINE | 19636336 | |
133 | ADM | DRUGGABLE GENOME, HORMONE ACTIVITY | INSULIN | INSULIN | 12668590 | |
133 | ADM | DRUGGABLE GENOME, HORMONE ACTIVITY | TPA | ALTEPLASE | 10848972 |
Page: 1 |